Perspective
Our work in Perspective
-
Shame Won’t Solve America’s Obesity Crisis: How Congress Can Help
If saving lives is the objective, then logic, clinical evidence and compassion dictate that Medicare should pay for preventing and treating obesity, starting now.
Categorized in -
The Inflation Reduction Act Is Already Killing Potential Cures
The law’s price controls do away with incentives for research and development of life-saving drugs.
Categorized in -
Multi-Year Medicare Physician Fee Freeze Threatens Access: Pair Relief With Reforms
With fees frozen, high inflation threatens access to care and has other consequences.
Categorized in -
CMS’s Alzheimer’s Coverage Policy Will Inhibit Access and Discourage Innovation
Individuals in underserved communities have to travel long distances, well beyond the 30-minute standard, to access clinical trial sites for Aduhelm.
Categorized in -
During the Height of the Opioid Epidemic, the Out-of-Pocket Price of Naloxone Increased by Over 500%
A jump in the out-of-pocket price of naloxone has likely made the lifesaving drug too expensive for most uninsured Americans.
Categorized in -
Bumpy Road Ahead for Lecanemab Approval
How to ensure lecanemab doesn’t wind up like aducanumab.
Categorized in -
Comments on AHRQ Analysis of Requirements for Coverage with Evidence Development
Researchers submitted a comment letter on the Agency for Healthcare Research and Quality (AHRQ)’s analysis for the Center for Medicare and Medicaid Services (CMS)’s requirements for Coverage with Evidence Development (CED) study design.
Categorized in -
Tweak the Affordable Care Act to Mandate Backstop Health Insurance
Universal coverage could be achieved through a “backstop” insurance that auto-enrolls uninsured patients when they seek care.
Categorized in -
How to Protect Yourself Against Wildfire Smoke This Fire Season: Five Tips in Everyday Language
Helpful tips on staying protected from wildfire smoke.
Categorized in -
Considerations in the Implementation of Multicancer Early Detection Tests
An analysis of the potential benefits and challenges of multi-cancer blood-based tests.
Categorized in